MBQ Pharma

Name: MBQ Pharma - AI Visibility Score
Creator: Engagemii
Published: 2026-07-07T23:16:17.029Z
License: https://creativecommons.org/licenses/by/4.0/

Unclaimed

AEO Score: 5/10

Monitoring for AI engine activity

In the Engagemii AEO index

mbqpharma.com

IG X f

What this score means

Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. MBQ Pharma just got measured.

5/10 means MBQ Pharma is borderline visible. AI bots can crawl your site but your structured-data signals are thin. You are at risk of being skipped when buyers ask AI for a recommendation.

About MBQ Pharma

Precision Targeting GTPases in Cancer, Autoimmunity and Fibrosis Precision Targeting GTPases in Cancer, Autoimmunity and Fibrosis MBQ-167 Our lead compound, MBQ-167, is a first-in-class therapeutic which simultaneously inhibits both Rac and CDC42, removing pre-existing metastases. MBQ-167 is currently in its Phase-1 study. Prevention of Metastatic Growth and

Key Topics

Precision Targeting GTPases in Cancer, Autoimmunity and Fibrosis

Our lead compound, MBQ-167, is a first-in-class therapeutic which simultaneously inhibits both Rac and CDC42, removing pre-existing metastases. MBQ-167 is currently in its Phase-1 study.

Prevention of Metastatic Growth and Removal of Pre-Existing Metastases

We are the first

The USFDA accepted the IND in June 2022 for the lead candidate MBQ-167 for a Phase 1 study in therapeutic-resistant advanced breast cancer.